Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
30 hedge funds and large institutions have $61.6M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
19% more capital invested
Capital invested by funds: $51.8M → $61.6M (+$9.8M)
15% more funds holding
Funds holding: 26 → 30 (+4)
99% less call options, than puts
Call options by funds: $5K | Put options by funds: $381K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
+$245K |
| 2 |
Renaissance Technologies
New York
|
+$120K |
| 3 |
CAM
ClariVest Asset Management
San Diego,
California
|
+$102K |
| 4 |
Morgan Stanley
New York
|
+$97.1K |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$78.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$2.48M |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$507K |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$317K |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$284K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$41K |
CORV Hedge Fund Activity: Q2 2016 in Review
30 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q2 2016, worth a combined $61.6M — up 19% from $51.8M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CORV positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was AlphaOne Investment Services, adding an estimated $245K. The largest seller was PointState Capital, exiting entirely with an estimated $2.48M sold.
- 30 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q2 2016, up from 26 in Q1 2016.
- Funds reported $61.6M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q2 2016, up 19% quarter-over-quarter.
- 8 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q2 2016 and 4 closed out, a net change of +4 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q2 2016 was AlphaOne Investment Services, an estimated $245K added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q2 2016 was PointState Capital, an estimated $2.48M sold.
Based on aggregated 13F filings for Q2 2016.